Persons with dispensed medicines; age and sex
| Sex | Ages | Medicine group (ATC) | Periods | Persons with medicines, relative (%) |
|---|---|---|---|---|
| Total male and female | Total age | A05 Bile and liver therapy | 2022* | 0.10 |
| Total male and female | Total age | A05A Bile therapy | 2022* | 0.10 |
| Total male and female | Total age | A05B Liver therapy, lipotropics | 2022* | 0.00 |
| Total male and female | Total age | A05C Bile therapy drugs and lipotropics | 2022* | 0.00 |
| Total male and female | Total age | A07X Other antidiarrheals | 2022* | 0.00 |
| Total male and female | Total age | A10X Other drugs used in diabetes | 2022* | 0.00 |
| Total male and female | Total age | A11C Vit A and D, incl.combin.of the two | 2022* | 5.55 |
| Total male and female | Total age | A11H Other plain vitamin preparations | 2022* | 0.00 |
| Total male and female | Total age | A11J Other vitamin products + combinat. | 2022* | 0.00 |
| Total male and female | Total age | A12C Other mineral supplements | 2022* | 0.05 |
| Total male and female | Total age | A14B Other anabolic agents | 2022* | 0.00 |
| Total male and female | Total age | A16 Other aliment.tract/metabol.products | 2022* | 0.02 |
| Total male and female | Total age | B02B Vitamin k and other hemostatics | 2022* | 0.08 |
| Total male and female | Total age | B03X Other antianemic preparations | 2022* | 0.00 |
| Total male and female | Total age | B06 Other hematological agents | 2022* | 0.00 |
| Total male and female | Total age | B06A Other hematological agents | 2022* | 0.00 |
| Total male and female | Total age | C01 Cardiac therapy | 2022* | 2.53 |
| Total male and female | Total age | C01E Other cardiac preparations | 2022* | 0.07 |
| Total male and female | Total age | C02K Other antihypertensives | 2022* | 0.01 |
| Total male and female | Total age | C03X Other diuretics | 2022* | 0.00 |
| Total male and female | Total age | C05B Antivaricose therapy | 2022* | 0.00 |
| Total male and female | Total age | C07C Beta block.agents / other diuretics | 2022* | 0.03 |
| Total male and female | Total age | C07D Beta block./thiazides/other diuret. | 2022* | 0.00 |
| Total male and female | Total age | C07F Beta block./other antihypertensives | 2022* | 0.00 |
| Total male and female | Total age | C09X Other renin angiotensin syst.agents | 2022* | 0.03 |
| Total male and female | Total age | D04 Antipruritics,incl antesthetics .... | 2022* | 0.00 |
| Total male and female | Total age | D06B Chemotherapeutics for topical use | 2022* | 0.73 |
| Total male and female | Total age | D06C Antibiotics/chemotherapeutics, comb | 2022* | 0.00 |
| Total male and female | Total age | D07X Corticosteroids, other combinations | 2022* | 0.22 |
| Total male and female | Total age | D11 Other dermatological preparations | 2022* | 0.66 |
| Total male and female | Total age | D11A Other dermatological preparations | 2022* | 0.66 |
| Total male and female | Total age | G02 Other gynecologicals | 2022* | 0.13 |
| Total male and female | Total age | G02C Other gynecologicals | 2022* | 0.04 |
| Total male and female | Total age | H03 Thyroid therapy | 2022* | 3.01 |
| Total male and female | Total age | H03C Iodine therapy | 2022* | 0.00 |
| Total male and female | Total age | J01D Other beta-lactam antibacterials | 2022* | 0.09 |
| Total male and female | Total age | J01X Other antibacterials | 2022* | 4.30 |
| Total male and female | Total age | J07X Other vaccines | 2022* | 0.00 |
| Total male and female | Total age | L01X Other antineoplastic agents | 2022* | 0.00 |
| Total male and female | Total age | L02 Endocrine therapy | 2022* | 0.56 |
| Total male and female | Total age | N01 Anesthetics | 2022* | 1.19 |
| Total male and female | Total age | N01A Anesthetics, general | 2022* | 0.04 |
| Total male and female | Total age | N01B Anesthetics, local | 2022* | 1.18 |
| Total male and female | Total age | N02B Other analgesics and antipyretics | 2022* | 0.02 |
| Total male and female | Total age | N07 Other nervous system drugs | 2022* | 0.69 |
| Total male and female | Total age | N07X Other nervous system drugs | 2022* | 0.04 |
| Total male and female | Total age | P01A Amoebiasis / other protozoal dis. | 2022* | 0.56 |
| Total male and female | Total age | P02 Anthelmintics | 2022* | 0.09 |
| Total male and female | Total age | R05X Other cold combination preparations | 2022* | 0.00 |
| Total male and female | Total age | R07 Other respiratory system products | 2022* | 0.01 |
| Total male and female | 0 to 15 years | A05 Bile and liver therapy | 2022* | 0.01 |
| Total male and female | 0 to 15 years | A05A Bile therapy | 2022* | 0.01 |
| Total male and female | 0 to 15 years | A05B Liver therapy, lipotropics | 2022* | 0.00 |
| Total male and female | 0 to 15 years | A05C Bile therapy drugs and lipotropics | 2022* | 0.00 |
| Total male and female | 0 to 15 years | A07X Other antidiarrheals | 2022* | 0.00 |
| Total male and female | 0 to 15 years | A10X Other drugs used in diabetes | 2022* | 0.00 |
| Total male and female | 0 to 15 years | A11C Vit A and D, incl.combin.of the two | 2022* | 0.35 |
| Total male and female | 0 to 15 years | A11H Other plain vitamin preparations | 2022* | 0.00 |
| Total male and female | 0 to 15 years | A11J Other vitamin products + combinat. | 2022* | 0.00 |
| Total male and female | 0 to 15 years | A12C Other mineral supplements | 2022* | 0.02 |
| Total male and female | 0 to 15 years | A14B Other anabolic agents | 2022* | 0.00 |
| Total male and female | 0 to 15 years | A16 Other aliment.tract/metabol.products | 2022* | 0.02 |
| Total male and female | 0 to 15 years | B02B Vitamin k and other hemostatics | 2022* | 0.01 |
| Total male and female | 0 to 15 years | B03X Other antianemic preparations | 2022* | 0.00 |
| Total male and female | 0 to 15 years | B06 Other hematological agents | 2022* | 0.00 |
| Total male and female | 0 to 15 years | B06A Other hematological agents | 2022* | 0.00 |
| Total male and female | 0 to 15 years | C01 Cardiac therapy | 2022* | 0.47 |
| Total male and female | 0 to 15 years | C01E Other cardiac preparations | 2022* | 0.00 |
| Total male and female | 0 to 15 years | C02K Other antihypertensives | 2022* | 0.00 |
| Total male and female | 0 to 15 years | C03X Other diuretics | 2022* | 0.00 |
| Total male and female | 0 to 15 years | C05B Antivaricose therapy | 2022* | 0.00 |
| Total male and female | 0 to 15 years | C07C Beta block.agents / other diuretics | 2022* | 0.00 |
| Total male and female | 0 to 15 years | C07D Beta block./thiazides/other diuret. | 2022* | 0.00 |
| Total male and female | 0 to 15 years | C07F Beta block./other antihypertensives | 2022* | 0.00 |
| Total male and female | 0 to 15 years | C09X Other renin angiotensin syst.agents | 2022* | 0.00 |
| Total male and female | 0 to 15 years | D04 Antipruritics,incl antesthetics .... | 2022* | 0.00 |
| Total male and female | 0 to 15 years | D06B Chemotherapeutics for topical use | 2022* | 0.10 |
| Total male and female | 0 to 15 years | D06C Antibiotics/chemotherapeutics, comb | 2022* | 0.00 |
| Total male and female | 0 to 15 years | D07X Corticosteroids, other combinations | 2022* | 0.03 |
| Total male and female | 0 to 15 years | D11 Other dermatological preparations | 2022* | 0.31 |
| Total male and female | 0 to 15 years | D11A Other dermatological preparations | 2022* | 0.31 |
| Total male and female | 0 to 15 years | G02 Other gynecologicals | 2022* | 0.00 |
| Total male and female | 0 to 15 years | G02C Other gynecologicals | 2022* | 0.00 |
| Total male and female | 0 to 15 years | H03 Thyroid therapy | 2022* | 0.11 |
| Total male and female | 0 to 15 years | H03C Iodine therapy | 2022* | 0.00 |
| Total male and female | 0 to 15 years | J01D Other beta-lactam antibacterials | 2022* | 0.01 |
| Total male and female | 0 to 15 years | J01X Other antibacterials | 2022* | 0.93 |
| Total male and female | 0 to 15 years | J07X Other vaccines | 2022* | 0.00 |
| Total male and female | 0 to 15 years | L01X Other antineoplastic agents | 2022* | 0.00 |
| Total male and female | 0 to 15 years | L02 Endocrine therapy | 2022* | 0.05 |
| Total male and female | 0 to 15 years | N01 Anesthetics | 2022* | 1.21 |
| Total male and female | 0 to 15 years | N01A Anesthetics, general | 2022* | 0.00 |
| Total male and female | 0 to 15 years | N01B Anesthetics, local | 2022* | 1.21 |
| Total male and female | 0 to 15 years | N02B Other analgesics and antipyretics | 2022* | 0.00 |
| Total male and female | 0 to 15 years | N07 Other nervous system drugs | 2022* | 0.01 |
| Total male and female | 0 to 15 years | N07X Other nervous system drugs | 2022* | 0.00 |
| Total male and female | 0 to 15 years | P01A Amoebiasis / other protozoal dis. | 2022* | 0.15 |
| Total male and female | 0 to 15 years | P02 Anthelmintics | 2022* | 0.07 |
| Total male and female | 0 to 15 years | R05X Other cold combination preparations | 2022* | 0.00 |
| Total male and female | 0 to 15 years | R07 Other respiratory system products | 2022* | 0.01 |
| Source: CBS. | ||||
Dataset is not available.
This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. Also, the number of dispensed defined daily doses (DDDs) are presented. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Personal Records Database (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.
Data are broken down by medicine group, age and sex.
Data available from: 2006
Status of the figures:
Figures for 2022 are provisional.
Changes as of December 20, 2023:
- Provisional figures for 2022 have been added, provisional figures of 2020 and 2021 have been made definite.
- Textual change: the description of drug group Y (Not filled in) has been replaced by Z (Not applicable). However, the underlying resources have remained the same. This category is assigned to products that do not have an ATC code according to the WHO ATC classification system.
When will new figures be published?
New figures will be published in the last quarter of 2024.
Description topics
- Persons with medicines, relative
- Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.